Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MBLY - US60741F1049 - Common Stock

10.5 USD
-0.58 (-5.23%)
Last: 1/16/2026, 4:36:04 PM
10.58 USD
+0.08 (+0.76%)
After Hours: 1/16/2026, 4:36:04 PM
Fundamental Rating

5

Taking everything into account, MBLY scores 5 out of 10 in our fundamental rating. MBLY was compared to 42 industry peers in the Automobile Components industry. While MBLY has a great health rating, there are worries on its profitability. MBLY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • MBLY had positive earnings in the past year.
  • In the past year MBLY had a positive cash flow from operations.
  • MBLY had negative earnings in each of the past 5 years.
  • MBLY had a positive operating cash flow in each of the past 5 years.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

  • With a Return On Assets value of -2.69%, MBLY is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • MBLY's Return On Equity of -2.82% is in line compared to the rest of the industry. MBLY outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

  • Looking at the Gross Margin, with a value of 48.66%, MBLY belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • MBLY's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

  • MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MBLY has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 9.80 indicates that MBLY is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.80, MBLY belongs to the best of the industry, outperforming 88.10% of the companies in the same industry.
  • MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.8
ROIC/WACCN/A
WACC8.6%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • MBLY has a Current Ratio of 6.46. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 6.46, MBLY belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
  • A Quick Ratio of 5.61 indicates that MBLY has no problem at all paying its short term obligations.
  • MBLY's Quick ratio of 5.61 is amongst the best of the industry. MBLY outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.46
Quick Ratio 5.61
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

  • MBLY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.50%.
  • Looking at the last year, MBLY shows a small growth in Revenue. The Revenue has grown by 7.61% in the last year.
  • MBLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.48% yearly.
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%

3.2 Future

  • MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.12% yearly.
  • The Revenue is expected to grow by 26.67% on average over the next years. This is a very strong growth
EPS Next Y46.12%
EPS Next 2Y29.7%
EPS Next 3Y35.21%
EPS Next 5Y53.12%
Revenue Next Year14.1%
Revenue Next 2Y10.75%
Revenue Next 3Y14.89%
Revenue Next 5Y26.67%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 24.42, MBLY is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as MBLY.
  • The average S&P500 Price/Earnings ratio is at 27.54. MBLY is around the same levels.
  • Based on the Price/Forward Earnings ratio of 24.97, the valuation of MBLY can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 64.29% of the companies listed in the same industry.
  • MBLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.31.
Industry RankSector Rank
PE 24.42
Fwd PE 24.97
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MBLY is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
  • 66.67% of the companies in the same industry are more expensive than MBLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.61
EV/EBITDA 51.61
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • MBLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MBLY's earnings are expected to grow with 35.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y29.7%
EPS Next 3Y35.21%

0

5. Dividend

5.1 Amount

  • MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (1/16/2026, 4:36:04 PM)

After market: 10.58 +0.08 (+0.76%)

10.5

-0.58 (-5.23%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-23
Earnings (Next)01-22
Inst Owners75.91%
Inst Owner Change0.32%
Ins Owners2.17%
Ins Owner Change1.15%
Market Cap8.54B
Revenue(TTM)1.94B
Net Income(TTM)-336.00M
Analysts74.71
Price Target19.59 (86.57%)
Short Float %13.46%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.99%
Min EPS beat(2)2.78%
Max EPS beat(2)23.2%
EPS beat(4)4
Avg EPS beat(4)11.44%
Min EPS beat(4)2.78%
Max EPS beat(4)23.2%
EPS beat(8)7
Avg EPS beat(8)7.16%
EPS beat(12)11
Avg EPS beat(12)15.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.68%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.14%
PT rev (3m)-1.35%
EPS NQ rev (1m)-1.6%
EPS NQ rev (3m)14.97%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)5.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.42%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)2.08%
Valuation
Industry RankSector Rank
PE 24.42
Fwd PE 24.97
P/S 4.41
P/FCF 13.61
P/OCF 12.33
P/B 0.72
P/tB 3.47
EV/EBITDA 51.61
EPS(TTM)0.43
EY4.1%
EPS(NY)0.42
Fwd EY4.01%
FCF(TTM)0.77
FCFY7.35%
OCF(TTM)0.85
OCFY8.11%
SpS2.38
BVpS14.67
TBVpS3.02
PEG (NY)0.53
PEG (5Y)N/A
Graham Number11.91
Profitability
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.66%
FCFM 32.4%
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score7
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 12.65%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion 541.41%
Profit Quality N/A
Current Ratio 6.46
Quick Ratio 5.61
Altman-Z 9.8
F-Score7
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y46.12%
EPS Next 2Y29.7%
EPS Next 3Y35.21%
EPS Next 5Y53.12%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%
Revenue Next Year14.1%
Revenue Next 2Y10.75%
Revenue Next 3Y14.89%
Revenue Next 5Y26.67%
EBIT growth 1Y-4.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.13%
EBIT Next 3Y55.54%
EBIT Next 5Y50.04%
FCF growth 1Y90.88%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y58.95%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%

MOBILEYE GLOBAL INC-A / MBLY FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


What is the valuation status for MBLY stock?

ChartMill assigns a valuation rating of 4 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Fairly Valued.


Can you provide the profitability details for MOBILEYE GLOBAL INC-A?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 3 / 10.


How financially healthy is MOBILEYE GLOBAL INC-A?

The financial health rating of MOBILEYE GLOBAL INC-A (MBLY) is 8 / 10.


What is the expected EPS growth for MOBILEYE GLOBAL INC-A (MBLY) stock?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to grow by 46.12% in the next year.